Table: Daito -2022/23 group results

Daito Pharmaceutical

14/07/2023 07:00

Jul 14 (Reuters)- 
          Daito Pharamaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                May 31, 2023    May 31, 2022   May 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             45.10           43.46          47.50                 
                 (+3.8 pct)                     (+5.3 pct)               
  Operating          5.21            6.55           4.80                 
                 (-20.5 pct)     (+10.9 pct)    (-7.8 pct)               
  Recurring          5.17            6.73           4.80                 
                 (-23.2 pct)     (+10.9 pct)    (-7.1 pct)               
  Net
  Net                3.60            4.67           3.30                 
                 (-22.9 pct)     (+9.9 pct)     (-8.3 pct)               
  EPS            250.39 yen      335.41 yen     229.70 yen               
  EPS Diluted    250.17 yen                                              
  Ann Div         60.00 yen       60.00 yen      60.00 yen               
  -Q2 Div         30.00 yen       25.00 yen      30.00 yen               
  -Q4 Div         30.00 yen       35.00 yen      30.00 yen               
  
  NOTE - Daito Pharamaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T